Detalhe da pesquisa
1.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
Inglês
| MEDLINE | ID: mdl-28049642
2.
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS.
Cancers (Basel)
; 13(4)2021 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33562393
3.
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission.
JCO Precis Oncol
; 1: 1-13, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35172507